NEW YORK (TheStreet) -- We need only look to the IPO of Castlight Health (CSLT) on Friday to appreciate Wall Street's tremendous interest in stocks that help with health insurance. Castlight helps employers control heath care costs by providing complex data on from various internal an external sources.
Castlight surged 149% on March 14 despite revenue of less than $13 million in 2013. Shares were slipping 5.2% in mid-day trading on Monday brining the San Francisco-based company's market capitalization down to a slightly less eye-popping $3.3 billion.
The lofty valuation assigned to Castlight clearly indicates intense interest in the sector. With this in mind, we're looking at other health care stocks that could see nice upward action in the coming week.
Benefitfocus Inc (BNFT) offers solutions that enable employers and insurance carriers to shop, enroll, manage, and exchange benefits information. It offers various products for insurance carriers, including eEnrollment. Shares have been under pressure over the last week into the Castlight IPO, due mostly to the end of its own IPO lockup period.
This unlock of shares has attracted short sellers, but because of the huge success of the Castlight IPO, Benefitfocus appears poised for a rebound. As you can see from the chart below, Benefitfocus likes to trade very close to its 20-day moving average, currently sitting 10% higher at $63.13.
Benefitfocus always moves back to this moving average if it strays above or below it. The 50 day moving average at $65 would be second target for traders initiating a long position in the stock. Traders initiating a trade at Friday's close could use the recent low of $56.15 as stops for a downside risk of 82c. With $63.13 and $65 as targets on the trade this offers a very attractive risk/reward ratio of 7.5-10.
Veeva Systems Inc (VEEV) helps life sciences companies in creating and maintaining a record of the healthcare professionals and healthcare organizations with which they interact. Veeva has also been under some downward pressure in recent days but again, given the huge market interest in the Castlight IPO, Veeva could see a nice bounce. With a forward PE of 98 the stock is not cheap but on its $210 million in annual revenues, when compared to the valuation Castlight is being afforded, shares could see buying pressure this week. More than half of Veeva's float is currently short, a potential powder-keg for a large short squeeze.
Traders looking for a trade in Veeva could consider a long entry on a break of the 20-day moving average at $33.73 with a $36 target followed by $38. Stops at the 50 day moving average at $33.03 gives a downside risk of 70c on the trade with a potential gain of $2.27 and $4.27.
At the time of publication, the author held no position in any of the other stocks mentioned. This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.